Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
After Novartis, Novo Nordisk (NVO.US) terminates two cardiovascular clinical trials

After Novartis, Novo Nordisk (NVO.US) terminates two cardiovascular clinical trials

智通财经智通财经2026/09/07 11:21
Show original
According to information from Zhisheng Finance APP, Novo Nordisk (NVO.US) has terminated two additional clinical trials for its experimental cardiovascular drug.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!